Wu described an allogeneic type of HSCT known as ‘haploidentical’, or derived from half-matched donor, such as a parent or child. Data from 2019 showed that in China, haploidentical HSCT ...

However, allogeneic stem cell transplant required ... All of these were integrated into a new system for haploidentical HSCT, named the ‘Beijing Protocol’ by Worldwide Network for Blood ...

The study "demonstrated that outcomes after [haploidentical stem cell transplant] in patients with severe thalassemia are ...

MSCs are isolated from the bone marrow of healthy adult human donors and are used to treat SR-aGVHD in patients who undergo allogeneic hematopoietic stem cell transplantation (allo-HSCT).